Mirum Pharmaceuticals Inc

NASDAQ:MIRM   1:06:55 PM EDT
25.46
+0.20 (+0.79%)
Earnings Announcements

Mirum Pharmaceuticals Reports First Quarter 2022 Financial Results And Provides Business Update

Published: 05/05/2022 12:48 GMT
Mirum Pharmaceuticals Inc (MIRM) - Mirum Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Business Update.
Qtrly Net Loss per Share $1.17.
Total Revenue for Q1 of 2022 Was $12.9 Million.
Q1 Earnings per Share View $-1.34, Revenue View $8.5 Million -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $15.25 Million
Adjusted EPS is expected to be -$1.14

Next Quarter Revenue Guidance is expected to be $18.98 Million
Next Quarter EPS Guidance is expected to be -$1.19

More details on our Analysts Page.